| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $306.6M | +3.6% |
| R&D Expense | $58.0M | -20.2% |
| SG&A Expense | $56.8M | -25.8% |
| Operating Income | -$69.8M | +45.0% |
| Income Tax | $333K | -6.5% |
| Net Income | -$69.5M | +41.2% |
| EPS (Basic) | -$1.15 | +45.0% |
| EPS (Diluted) | -$1.15 | +45.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249.6M | +134.9% |
| Short-term Investments | $142.4M | -32.7% |
| Accounts Receivable | $57.2M | -5.2% |
| Current Assets | $465.6M | +18.4% |
| Total Assets | $858.9M | +22.4% |
| Current Liabilities | $325.9M | +266.0% |
| Long-term Debt | $382.4M | +67.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.6M | +144.0% |
| Capital Expenditures | $1.6M | +30.7% |
| Investing Cash Flow | -$22.9M | -212.9% |
| Financing Cash Flow | $151.7M | +5458.5% |
| Free Cash Flow | $12.9M | +137.7% |
| Total Liabilities |
| $493.7M |
| +47.4% |
| Stockholders' Equity | $365.2M | -0.5% |